Error: Could not add to watchlist. X
+ Watchlist

Halozyme Therapeutics Inc

HALO:US
NASDAQ GS
12.27
USD
0.23
1.91%
As of 8:10 PM EST 2/24/2017
Open
11.84
Day Range
11.82 - 12.27
Volume
1,253,648
Previous Close
12.04
52Wk Range
7.52 - 14.38
1 Yr Return
48.73%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
11.84
Day Range
11.82 - 12.27
Volume
1,253,648
Previous Close
12.04
52Wk Range
7.52 - 14.38
1 Yr Return
48.73%
YTD Return
24.19%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.57
Market Cap (b USD)
1.589
Shares Outstanding (m)
129.490
Price/Sales (TTM)
9.79
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.43%
% Price Change
+0.39%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology, and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
Address
11388 Sorrento Valley Road
San Diego, CA 92121
United States
Phone
1-858-794-8889
Show More